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THE CENTRAL NEUROMEDIN U (NMU) signaling system has emerged as a potential target for the regulation of energy balance and hence, body fat. NMU was isolated initially from porcine spinal cord (17) and subsequently from other species (4, 6) . In mammals, it has a rather widespread distribution in central and peripheral tissues (1, 12) . In addition to energy balance regulation, NMU has been designated in a number of physiological roles that include smooth muscle contraction, blood pressure regulation, nociception, and the regulation of adrenocortical function (for review, see Ref. 2) . The diversity of physiological actions of NMU together with the lack of published data showing the presence of detectable levels of NMU in blood suggests that it is a local/paracrine hormone or neurotransmitter rather than a circulating endocrine signal.
In the central nervous system (CNS), NMU immunoreactive fibers are distributed throughout the brain, with highest levels in the nucleus accumbens, medial thalamus, brainstem, and several hypothalamic areas that have an established role in energy balance homeostasis, such as the paraventricular, ventromedial, dorsomedial, and arcuate nuclei (1, 5, 23) . NMU immunoreactive cell bodies and NMU mRNA expression have been identified in the median eminence and the arcuate nucleus (1, 13, 23) .
Two G protein-coupled receptors for NMU (designated NMUR1 and NMUR2) have been identified and their distribution described (13) . NMUR1 and NMUR2 correspond to the orphan receptors FM3 (24) and FM4 (13) , respectively. The distribution of NMUR1 appears to be confined mainly to peripheral tissues, especially the gastrointestinal tract (13) . NMUR2 is expressed in a number of peripheral tissues (20, 22) ; however, highest levels are found in the CNS, notably in the arcuate and paraventricular nuclei of the hypothalamus and in discrete cell groups in the hippocampus, medulla, and spinal cord (13, 20) .
Considerable data support a role for NMU in the regulation of the energy balance at the CNS level. Acute central NMU injection suppresses food intake (11, 13, 14, 18, 27) , increases energy expenditure and core body temperature, and stimulates locomotor activity (11, 18) . Intracerebroventricular (icv) injection of NMU IgG has been shown to block the effects of centrally administered NMU on food intake in fasted rats and, more importantly, increases food intake in satiated rats, implying a role for endogenous NMU in the regulation of food intake and hence, energy balance (15) . However, repeated intraparaventricular nucleus (PVN) injection of NMU (twice daily for 7 days) had no effect on food intake or body weight (25) . The effects of NMU are short lived and may be energy state dependent, since the effect is observed during fasting (14) and during normal nighttime food intake (13) but not in freely feeding satiated rats (14) . In the semichronic study in which NMU was administered intra-PVN to satiated rats on a standard diet, no acute reduction in food intake was seen (25) , although the PVN appears to be the most sensitive site for the acute anorectic effects of NMU in fasted rats (27) .
Male mice overexpressing NMU are lean and hypophagic, have increased insulin sensitivity, and are partially protected from diet-induced obesity (DIO) (16) . Conversely, male NMUknockout mice on a standard chow diet start to diverge in body weight already at 4 wk of age, increasing to a 35% difference compared with wild-type littermates at 32 wk of age. The reason for the obese phenotype in the NMU knockouts appears to be a combination of increased food intake and decreased energy expenditure (10) . Unexpectedly, NMU receptor 2 (NMUR2)-knockout mice do not differ in body weight from wild-type mice, although the effects of acute icv NMU injections on food intake are absent in these mice, suggesting that NMUR2 mediates NMU's central effects on food intake (28) .
To our knowledge, there are no published reports on the effects of continuous central administration of NMU on body weight and food intake. Therefore, we sought to attempt to clarify the effects of long-term central (icv infusion) exposure to NMU on body weight, food intake, and fat mass in normal mice. We also investigated the importance of the NMUR2, using NMUR2-null mice, on energy balance and fastinginduced feeding, DIO, and long-term central NMU treatment.
METHODS
Animals and diets. NMUR2-null mice were generated using a bacterial artificial chromosome obtained from Genome Systems (St. Louis, MO). A 14-kb genomic DNA fragment containing exon 1 of the NMUR2 gene was subcloned into pBluescript and sequenced with Genome Priming System (New England BioLabs). To generate the NMUR2 targeting vector, a 0.77-kb DNA fragment, which contained 393 bp upstream intron, 104 bp of 5Ј-UTR, and 274 bp coding sequence of exon 1, was deleted and replaced with a loxP-flanked neo cassette using standard cloning technique (Fig. 1A) . The targeting vector was linearized and electroporated into R1 mouse embryonic stem (ES) cells, and ES cell clones were selected with G418 (300 g/ml). ES cell clones that successfully underwent homologous recombination were screened by PCR, and the results were confirmed by Southern blotting (Fig. 1B) . The targeted ES cells were injected into C57BL/6 blastocysts that were transplanted into the uterus of pseudopregnant female mice. Chimeric animals were mated with C57BL/6 to produce agouti heterozygous animals. The neo cassette was deleted by breeding the heterozygous mice to R26Cre mice with C57BL/6 background. The resulting NMUR2-null mice were then crossed onto a C57BL/6 background to yield N3 animals, on which the experiments reported in this study were conducted. Expression of NMUR2 mRNA was measured in brain, cerebellum, and spinal cord from littermates of NMUR2-null, heterozygous, and wild-type mice, respectively. Total RNA was extracted with a standard method. Reverse transcription was run with SuperScript First-Strand (Invitrogen) followed by PCR using primers located in the deleted region of the exon 1 and downstream exons (RP1, forward: 5Ј-GGCAGTCT-CAGACTTGCTGGTC-3Ј; RP2, reverse: 5Ј-GTCCAACAGATAG-CAAA-CACG-3Ј; RP3, forward: 5Ј-CGTGTTTGCTATCTGTTG-GAC-3Ј; and RP4, reverse: 5Ј-CCCGCATCCTCTGTCAGCTCC-3Ј) (Fig. 1C) . Genotyping by PCR was preformed using primers that detected the wild-type and null allele (forward: 5Ј-TGAGGTCGT-TAGGCAAGGCTA-3Ј; reverse: 5Ј-GTGCCACAACTCGTAGAC-CTC-3Ј).
Female and male C57BL/6 mice from Harlan were used in additional experiments. All animals were housed in a temperature-controlled room with a 12:12-h light-dark cycle. They were fed either a standard chow diet (R3; Lactamin, Vadstena, Sweden), a high-fat diet (no. D12492; Research Diets, New Brunswick, NJ), or a highly palatable cafeteria diet consisting of soft chocolate/cocoa cake (Delicato; Fazer Bageri, Solna, Sweden), milk chocolate (Kraft Foods Sverige, Väsby, Sweden), fatty cheese (Swedish household cheese; Arla Foods, Stockholm, Sweden), and standard chow. All experimental procedures and protocols used in the present study were approved by the local ethics committee, University of Gothenburg, Gothenburg, Sweden.
Body weight, feeding, indirect calorimetry, and behavioral measurements in NMUR2-null mice on a standard chow diet. Body weight and food intake were recorded once/wk between 3 and 8 wk of age (and at 18 wk), and tail-body length (from tip of the snout to the tail bade) was measured at 3 and 7 wk of age in individually housed NMUR2-null and wild-type littermate mice. Morphological appearances such as body posture, signs of dehydration, fur condition, whiskers, nose, eyes, teeth, and limbs were examined for abnormalities between 4 and 6 wk of age. Furthermore, cageside observations were used to study normal behavior such as nesting, grooming, rearing, climbing, and sniffing, as described previously (8) . Any abnormal gait, passivity, or behavior was noted. The mouse was then placed in an empty cage and studied for abnormal spontaneous behavior like freezing in a corner, panic running, lack of exploratory behavior, and excessive grooming. At 8 wk of age, respiratory quotient, oxygen consumption, locomotor activity, food, and water intake were measured for 48 h at thermoneutrality using an indirect calorimetry system (Columbus Instruments, Columbus, OH) in a subset of male NMUR2-null and wild-type mice, as described previously (8) . Feces were collected following the indirect calorimetry measurements and fecal energy content determined using a bomb calorimeter (C 5000; IKA Werke GmbH & KG). Following the indirect calorimetry measurements, body composition was determined by dual-energy X-ray absorptiometry (DEXA) using a PIXImus imager (GE Lunar, Madison, WI). Open-field activity was monitored in 50 ϫ 50-cm sound-isolated boxes at 9 wk of age in the remaining NMUR2-null and wild-type mice, and horizontal activity (indicated by 2 or more beam breaks in a row), peripheral activity, rearing, and corner time were determined (8) .
Body weight and feeding following an overnight fast in NMUR2-null mice. Twelve-week-old male NMUR2-null and wild-type littermate mice on a standard chow diet were fasted for 16 h overnight. Body weight regain and food intake were recorded at 0, 1, 3, and 24 h following the reintroduction of standard chow at 0900.
Body weight in DIO NMUR2-null mice on a high-fat diet. Grouphoused male and female wild-type and NMUR2-null mice were put on a high-fat diet (Research Diets) at 9 wk of age. Body weights were recorded once/wk for 9 wk.
Intracerebroventricular surgery, implantation of osmotic pumps, and body composition measurements. For acute icv injection experiments, NMUR2-null and wild-type littermates were implanted with guide cannulae directed at the dorsal third ventricle, as described previously (7) . For the long-term central treatment experiments, osmotic pumps (Alzet, Cupertino, CA) designed to deliver drugs for 7 or 14 days were prepared according to the manufacturer's protocol and coupled to a mouse brain infusion kit (Alzet) prior to implantation. The cannula of the brain infusion kit was directed at the dorsal third ventricle, 0.94 mm posterior to the bregma and 2.5 mm below the surface of the skull. The brain infusion kits were held in position by dental cement (Heraeus Kulzer) attached to two stainless steel screws driven into the skull. The pumps were filled with NMU (Alpha Diagnostics, San Antonio, TX) dissolved in ringer vehicle solution (Merck, Darmstadt, Germany) for delivery of NMU (8 g⅐day Ϫ1 ⅐mouse Ϫ1 ) or vehicle. In association with the surgical implantation of the osmotic pump and at the end of the treatment period, body fat and lean body mass were determined by DEXA for all central NMU infusion experiments.
Central NMU treatment in lean female C57Bl/6 mice. Ten-weekold individually housed female C57/BL6 mice on a standard chow diet were treated with NMU centrally for 14 days. Body weight and food intake were measured at 7 and 14 days. Following 3 days of treatment, behavior was recorded and scored for 30 min during a mild stress test consisting of exposure to 130 lux subsequent to removal of the lid and food hopper of the home cage. Grooming, paw licking, rearing activity, and risk assessment were scored. Twenty-four-hour respiratory quotient and oxygen consumption were measured on treatment day 7 using the Somedic metabolic system INCA (Somedic, Hörby, Sweden).
Central NMU treatment in DIO female C57Bl/6 mice. Eight-weekold female C57BL/6 mice were put on a highly palatable cafeteriastyle diet for 12 wk. The animals were separated and housed individually 1 wk prior to implantation of the brain infusion kits delivering NMU or vehicle for 7 days. Body weight and food intake were monitored during the treatment period.
Central NMU treatment in lean and DIO male C57Bl/6 mice. Eight-week-old male C57BL/6 mice were fed either a high-fat diet (Research Diets) or standard chow for 6 wk. At 13 wk of age, lean (standard chow fed) and DIO (high-fat diet fed) mice were implanted with brain infusion kits delivering NMU or vehicle for 9 days. At surgery, DIO mice weighed significantly more than lean mice (37.9 Ϯ 0.7 and 27.8 Ϯ 0.6 g, respectively, P Ͻ 0.001). Body weight and food intake were determined during the treatment period.
Central NMU treatment in DIO male and female NMUR2-null and wild-type mice. To test the importance of NMUR2 in NMU-mediated body weight loss, 24-wk-old male and female wild-type and NMUR2-null mice fed a high-fat diet (Research Diets) for 4 and 6 wk, respectively, were implanted with brain infusion kits delivering NMU or vehicle for 9 days. Body weight and food intake were recorded.
Statistical analysis. Data were analyzed using Student's t-test, two-way analysis of variance (ANOVA), and repeated-measures twoway ANOVA using the SPSS program (SPSS, Chicago, IL). The significance level was set at a P Ͻ 0.05. All data are presented as means Ϯ SE. P values reported are from Student's t-test unless stated otherwise.
RESULTS
Generation of NMUR2-null mice. NMUR2-null mice were created by replacing 393 bp of upstream intron, 104 bp of 5Ј-UTR, and 274 bp coding for exon 1 with a loxP-flanked neo cassette (Fig. 1A) . Following transfection with linearized DNA construct, ES cell clones were selected with G418 and screened for homologous recombination by PCR and the results confirmed by Southern blotting (Fig. 1B) . Chimeric animals were mated with C57BL/6 mice to produce heterozygous mice that were intercrossed further with R26Cre mice on a C57BL/6 background to eliminate the neo cassette. NMUR2-null mice (carrying 2 copies of the mutant NMUR2 allele) and their littermates, which included heterozygous (carrying 1 copy of the mutant NMUR2 allele and 1 wild-type allele) and wild-type Fig. 2 . Deletion of NMUR2 increase body weight and body fat in DIO female mice. A: body weight of male and female wild-type and NMUR2-null mice maintained on a high-fat diet (60% fat) for 9 wk from the age of 9 wk. Lean body mass (B) and fat mass (C) were determined by dual-energy X-ray absorptiometry (DEXA). Data represent means Ϯ SE. For A-C, n ϭ 7 male and 9 female wild-type and 7 male and 11 female NMUR2-null mice. *P Ͻ 0.05, Statistical comparisons were done by repeated-measures 2-way ANOVA (body weight) and Student's t-test (DEXA measurements). mice (carrying 2 copies of the wild-type allele), were viable and were born in the expected Mendelian ratios upon breeding of heterozygous. To validate the deletion of the selected DNA fragment of the NMUR2 allele, total RNA from brain, cerebellum, and spinal cord of littermates of NMUR2-null, heterozygous, and wild-type mice was extracted and converted into cDNA followed by PCR using primers located in the deleted region of the exon 1 and downstream exons (Fig. 1C) .
To assess that the deletion of the NMUR2 resulted in a nonfunctioning NMUR2, NMU (10 g) was injected icv into wild-type and NMUR2-null mice. It was found that, within 10 min following the injection of NMU, wild-type mice responded with increased grooming and paw licking, whereas NMUR2-null mice were unaffected (data not shown).
NMUR2-null mice fed standard chow have normal body weight and energy balance. To determine the physiological significance of NMUR2 on long-term body weight homeostasis, body weight was measured weekly during the first 5 wk following weaning (at 3 wk of age) and then again at 18 wk of age in male and female wild-type and NMUR2-null mice. In accordance with previous studies in another NMUR2-knockout model (28), we found no significant difference in body weight between wild-type and NMUR2-null mice fed normal chow at any time point. Furthermore, no difference in body length was found between male wild-type and NMUR2-null mice at 3 wk of age (8.27 Ϯ 0.08 and 8.11 Ϯ 0.15 cm, respectively) or at 7 wk of age (9.97 Ϯ 0.11 and 9.90 Ϯ 0.66 cm, respectively).
At 8 wk of age, male mice were subjected to indirect calorimetric measurements for 48 h. No significant differences in food intake, energy expenditure, respiratory quotient, activity, or fecal energy content were found between NMUR2-null and wild-type mice (data not shown). To further challenge the energy balance regulation of NMUR2-null mice on a standard diet, 12-wk-old NMUR2-null and littermate wild-type male mice were fasted for 16 h overnight. At 24 h following reintroduction of normal chow, body weight regain was improved by 54% in NMUR2-null mice relative to wild-type mice (P Ͻ 0.05) without any effects on feeding. NMUR2-null mice showed no change in energy absorption (wild type 42.5 Ϯ 4.1 kJ, null mice 52.9 Ϯ 5.9 kJ; P ϭ 0.16) or fecal energy content at 24 h following reintroduction of food (wild type 21.5 Ϯ 0.9 kJ, null mice 19.2 Ϯ 0.7 kJ; P ϭ 0.07). DEXA analysis of male wild-type and NMUR2-null mice at 8 wk showed no differences in body fat content or lean mass, and upon dissection, no differences in individual fat pad weights could be found (data not shown). Furthermore, no difference in behavior (open field), morphology, or cageside behavior was found between NMUR2-null and wild-type mice (data not shown).
Deletion of NMUR2 increases body weight and body fat in female but not male DIO mice. To further study the physiological role of NMUR2 in body weight regulation, 9-wk-old male and female wild-type and NMUR2-null mice were challenged with a high-fat diet (60% calories from fat) for 9 wk. At the end of this period, male NMUR2-null mice showed no difference in body weight compared with wild-type littermates ( Fig. 2A) . However, female NMUR2-null mice increased their body weight ϳ10% after 9 wk on a high-fat diet relative to wild-type mice (repeated-measures 2-way ANOVA, P Ͻ 0.05; Fig. 2A ). DEXA analysis revealed that the body fat of female NMUR2-null mice fed a high-fat diet was increased by 29% (P ϭ 0.052) without any change in lean mass (Fig. 2, B and C) . Male NMUR2-null mice did not differ in body fat or lean mass compared with wild-type mice (Fig. 2, B and C) . Fig. 4 . Central (icv) infusion of NMU for 8 days decreases body weight, fat mass, and energy intake in male DIO C57Bl/6 mice but not in lean male mice. A: body weight loss was increased in obese but not in lean male mice following NMU treatment compared with vehicletreated obese mice. B: total energy intake was decreased by 37% in obese mice treated with NMU compared with vehicle-treated obese mice. No difference was found in total energy intake between NMU and vehicle-treated lean mice. C: lean body mass was decreased by NMU treatment in both lean and obese male mice. D: dissected fat pad weight was decreased in NMU-treated obese male mice compared with vehicle-treated obese male mice. Data represent means Ϯ SE; n ϭ 8 -10 in each group. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001, 2-way ANOVA followed by Bonferroni post hoc test.
Effects of long-term central NMU treatment.
To study the long-term effects of central NMU treatment on body weight and feeding, 8-wk-old lean female C57BL/6 mice fed a standard chow diet (initial fat percentage 16%) were implanted with a brain infusion kit coupled to an osmotic pump for continuous NMU delivery for 14 days. In accord with previous studies of repeated intra-PVN injections of NMU (25), no effect on body weight was found (Fig. 3A) . Furthermore, there was no difference in food intake of standard chow between vehicle-and NMU-treated mice (Fig. 3B) . However, following 7 days of NMU treatment, daytime respiratory quotient was decreased by 24% (vehicle 84.1 Ϯ 1.5, NMU 74.2 Ϯ 1.5; P Ͻ 0.05, repeated-measures 2-way ANOVA), and this decrease tended to be sustained also during the dark period (vehicle 83.2 Ϯ 3.1, NMU 81.8 Ϯ 1.8; P ϭ 0.12, repeated-measures 2-way ANOVA). No significant difference in energy expenditure between vehicle-and NMU-treated mice was observed (data not shown). DEXA analysis performed by the end of the 14-day treatment period showed no differences in fat mass or lean mass (Fig. 3, C and D) .
In an attempt to assess whether or not NMU treatment influences behavior, animals were exposed to a mild stress test in their home cage, and their behavior was scored. No differences in activity, grooming, rearing, paw licking, or nesting were observed between the vehicle-and NMU-treated mice (data not shown).
Since NMU has been shown to be anorexigenic and since female NMUR2-null mice became more obese than wild-type mice on a high-fat diet, the effects of continuous icv treatment with NMU for 7 days were investigated in DIO female C57/ BL6 mice (initial fat percentage 50%). NMU treatment was found to decrease body weight significantly compared with vehicle treatment (12.0 and 4.5%, respectively, P Ͻ 0.05; Fig.  3E ). The body weight decrease was coupled to a 20% decrease in caloric intake (P Ͻ 0.01; Fig. 3F ). Moreover, there was a significant difference in the preference of foods between vehicle-and NMU-treated mice such that NMU treatment decreased the intake of chocolate/coconut cake by 54% (vehicle 30.0 Ϯ 2.4%, NMU 16.3 Ϯ 1.2%, P Ͻ0.001) and increased standard chow and milk chocolate intake by 57 (vehicle 22.5 Ϯ 1.5%, NMU 14.4 Ϯ 1.3%, P Ͻ 0.001) and 166% (vehicle 2.8 Ϯ 1.3%, NMU 7.5 Ϯ 1.3%, P Ͻ 0.01), respectively, when normalized to total caloric intake. The DEXA analysis revealed a greater loss of lean mass and a trend toward a reduced loss of fat mass in NMU-treated mice (P Ͻ 0.01 and P ϭ 0.086, respectively; Fig. 3, G and H) .
The effect of central NMU treatment was also studied in DIO male mice. At the start of treatment, the percentage fat was 13.5% for lean C57Bl/6 mice maintained on a standard chow diet and 36.9% for obese C57Bl/6 mice maintained on a high-fat diet. Central NMU treatment decreased body weight compared with vehicle treatment in obese male mice but not in lean mice (P Ͻ 0.001, 2-way ANOVA followed by Bonferroni post hoc test; Fig. 4A ). Energy intake was decreased following NMU treatment in obese but not in lean male mice (P Ͻ 0.01, 2-way ANOVA followed by Bonferroni post hoc test; Fig. 4B ). The effect of NMU to decrease feeding in obese mice was seen during both the night and day periods. Furthermore, no difference in day-and nightime feeding was observed in lean animals following NMU treatment. NMU treatment decreased lean mass in both lean and obese mice (P Ͻ 0.01, effect of treatment, 2-way ANOVA; Fig. 4C ). However, fat mass was Fig. 5 . Effects of central (icv) infusion of NMU to decrease body weight and energy intake in DIO male wild-type and NMUR2-null mice. A: body weight loss was increased by NMU treatment compared with vehicle treatment in both male wild-type and NMUR2-null mice. B: total energy intake was decreased by 40% in wild-type mice and 45% in NMUR2-null mice following treatment with NMU compared with vehicle treatment. No difference was found in total energy intake between vehicle-treated wild-type and NMUR2-null mice C and D: changes in lean mass and fat mass determined by DEXA. Data represent means Ϯ SE; n ϭ 3-5 animals/group. **P Ͻ 0.01, effect of treatment using a 2-way ANOVA.
only decreased in DIO mice following central NMU treatment compared with vehicle treatment (P Ͻ 0.05, 2-way ANOVA followed by Bonferroni post hoc test; Fig. 4D ).
To investigate the involvement of NMUR2 in the catabolic and anorexic effects of long-term central NMU treatment, 24-wk-old male and female wild-type and NMUR2-null mice on a high-fat diet were implanted with icv catheters coupled to osmotic pumps delivering NMU. In male mice, loss of body weight was greater following NMU treatment compared with vehicle treatment, regardless of genotype (P Ͻ 0.01, effect of treatment using 2-way ANOVA; Fig. 5A ). In contrast, body weight loss in female mice following NMU treatment was observed only in wild-type mice (P Ͻ 0.05, 2-way ANOVA followed by Bonferroni post hoc test; Fig. 6A ). Total energy intake was decreased by ϳ40 -45% by NMU treatment in male wild-type and NMUR2-null mice compared with vehicle treatment (P Ͻ 0.001, effect of treatment using 2-way ANOVA; Fig. 5B ). In female mice, no significant difference in energy intake could be found between the groups when a two-way ANOVA was used (Fig. 6B) . However, when only wild-type female mice were compared, NMU treatment tended to decrease energy intake compared with vehicle treatment (P ϭ 0.08). The DEXA analysis revealed an increased loss of fat mass in NMU-treated male mice compared with vehicle treatment (P Ͻ 0.01, effect of treatment using 2-way ANOVA; Fig.  5D ), but no difference in lean mass was observed between treatment groups in any of the genotypes (Fig. 5C ). In female wild-type and NMUR2-null mice, NMU treatment decreased lean mass (P Ͻ 0.05, effect of treatment using 2-way ANOVA; Fig. 6C ). However, no significant effect on fat mass was observed (Fig. 6D) .
DISCUSSION
The data presented in the present study suggest that increased activation of the central NMU receptor signaling system is able to exert beneficial effects on body weight, body composition, and energy balance in rodent models of DIO but not lean animals on a standard diet. Studies in NMUR2-null mice indicated that central NMU signaling via NMUR2 appears to be important for these effects in female but not male mice.
Interest in the central NMU signaling system as a metabolic target for the treatment of obesity was first highlighted by the anorexigenic effects of acute central NMU treatment to rodents (11, 13, 14, 18, 19, 27) together with the marked hyperphagia and obesity observed in NMU-knockout mice (10) . However, repeated central injections of NMU into the PVN, an area with dense expression of NMUR2, to rats on a standard diet for 7 days did not alter body weight or food intake (25) . Likewise, we found that icv infusion of NMU for 1 wk had no effect on feeding or body weight in lean female (and male) C57Bl/6 mice on a standard diet. This was also the case when the icv infusion was prolonged to 14 days. Thus, 14 days of chronic central NMU treatment did not alter total body fat or lean mass. However, we did observe a decrease in respiratory quotient at 7 days of NMU treatment, indicative of an increase in fat utilization.
To further challenge the role for central NMU signaling in energy balance and body weight homeostasis, we examined the effects of central NMU treatment in DIO C57Bl/6 mice. NMU treatment in both male and female DIO mice caused a loss of body weight compared with vehicle treatment, reflected by a Fig. 6 . Effects of central (icv) infusion of NMU on body weight, energy intake, and body composition in DIO female wild-type and NMUR2-null mice. A: NMU treatment increased body weight loss in female wildtype but not in female NMUR2-null mice. B: energy intake was unaffected by NMU treatment in both wildtype and NMUR2-null mice compared with vehicle treatment. C and D: changes in lean mass and fat mass determined by DEXA. Data represent means Ϯ SE; n ϭ 4 -5 animals/group *P Ͻ 0.05, 2-way ANOVA followed by Bonferroni post hoc test. loss of fat mass as well as lean mass. Central NMU treatment reduced calorie intake in both DIO female and male mice but not in animals on a standard chow diet, inferring that high-fat feeding may increase sensitivity to NMU's central anorexigenic effects. Moreover, in animals on a cafeteria-style diet, treatment with NMU centrally caused a change in food preference such that intake of chocolate/coconut cake decreased and intake of standard chow and milk chocolate increased (data not shown). Taken together, our data suggest that central sensitivity to NMU is regulated by states of energy balance. Thus, DIO mice appear to be more responsive to central NMU exposure, which likely reflects altered endocrine or metabolic signaling, for example, via increased adipokine signaling (e.g., increased leptin and/or decreased leptin resistance). Supportively, there are indications of cross-talk between central NMU and leptin signaling, in this case in the regulation of bone metabolism, which also appears to be sex specific (21) . It will be interesting to discover whether there are interactions between these signaling systems in the regulation of energy balance. Previous studies have shown that hypothalamic NMU expression is positively regulated by nutritional status as well as in models of obesity such as the ob/ob mice (9) .
The role for the central NMU signaling system in body weight regulation has been challenged by the lack of body weight phenotype in mice with deletion of the NMUR2 (28), the receptor found predominantly in the CNS. Thus, when fed a standard diet, body weight and daily food intake did not differ between the NMUR2-knockout and wild-type mice (28) , findings that we have been able to confirm in the present study using a different NMUR2-null model. Compared with this previous NMUR2-knockout study, the only difference we detected was an improved body weight recovery following an overnight fast in our NMUR2-null mice, which is perhaps more in line with the predicted anorectic effect of NMU. However, we now report that, when fed a high-fat diet for 9 wk, female (but not male) NMUR2-null mice show increased body weight and altered body composition compared with wild-type mice. Furthermore, this sex difference is also observed in NMU-treated NMUR2-null mice fed a high-fat diet. In male mice, central NMU treatment decreased body weight and food intake in both DIO wild-type and DIO NMUR2-null mice, whereas only DIO wild-type females were responsive to central NMU treatment. Thus, NMUR2 appears to be more important for the long-term antiobesity effects of NMU in DIO female mice than in DIO male mice.
In contrast to the central leptin signaling system, which decreases responsiveness to leptin with the progression from normal weight to the obese state, our data show increased sensitivity to NMU in obese vs. normal-weight mice. The implication is that the central NMU signaling system provides a new possible therapeutic strategy to suppress food intake in obesity. In the context of development of the central NMU signaling system as a therapeutic target for obesity prevention and/or treatment, it is important to consider the diversity of physiological functions attributed to NMU and whether these are likely to give rise to adverse effects. For example, a role for the central NMU signaling system in nociception has been suggested by studies showing increased pain sensitivity following central injection of NMU to mice (3), effects most likely mediated through the NMUR2 but not NMUR1 (26) . Given the nociceptive effects of NMU, together with its effects on the hypothalamic-pituitary-adrenal stress axis, it has been proposed that its anorexigenic response may be secondary to increased nociceptive and/or stress responses induced by NMU (28) . In the present study, we found no effect on food intake, body weight, or adverse behavior in mice on a standard diet, arguing against an important role for the nociceptive and/or stress response to chronic NMU treatment in the long-term regulation of body weight.
Thus, using models of central NMU treatment and suppressed central NMU signaling (NMUR2-null mice), we substantiate and extend previous studies supporting the idea that this system plays a role in the regulation of body weight and energy balance and therefore remains a therapeutic target for body weight reduction. Our studies in NMUR2-null mice provide evidence for an antiobesity and anorexigenic role of the central NMU signaling system in DIO that is most likely mediated via NMUR2 in female but not in male mice.
